Results presented here showed intra-articular injections of platelet-rich plasma may be inferior to corticosteroid injections for treatment of mild to moderate knee osteoarthritis. “The take-home ...

More than 500 million people around the world live with osteoarthritis. The knee is affected more often than any other joint, ...

Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis ...

Our new review, published by the independent, international group the Cochrane Collaboration, looks at all 25 randomised trials of stem cell injections for knee osteoarthritis that have been ...

Successful completion of groundbreaking stem cell trial for knee osteoarthritis marks a significant medical milestone.

With Japan’s rapidly aging population, the prevalence of knee osteoarthritis is expected to rise. This has led to an increased demand for non-surgical treatment options, such as knee hyaluronic acid ...

Swiss pharma major Novartis has discontinued development of its experimental treatment QUC398 for knee osteoarthritis, ending ...

The Feel Good Knees program is backed by a no-questions-asked, 60-day money-back guarantee. If users don't feel a measurable improvement in pain, mobility, or overall comfort, they can request a full ...

The Department of Health - Abu Dhabi (DoH), has successfully completed a groundbreaking clinical trial in Abu Dhabi, in ...